Manuel Aivado
CIK: 0001709603
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ALRN
Aileron Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Aivado Manuel
Aivado Manuel (SEC CIK 0001709603) files insider reports with the SEC as Director of Aileron Therapeutics, Inc. (ALRN).
Signal8 holds 2 ownership filings by Aivado Manuel, all Form 4s, filed between Dec 6, 2024 and Jul 23, 2025. Those filings report 2 transactions, from Dec 2, 2024 to Jul 23, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Aivado Manuel's filings is in AUSTIN, TX.
Recent filings by Aivado Manuel
Other insiders filing for Aileron Therapeutics, Inc. (ALRN)
- VON RICKENBACH JOSEF H, Director
- WINDSOR JAMES BRIAN, President and CEO
- Musso Alan A, Director
- Fairey William, Director
- Ambros Reinhard J., Director